Skip to search boxSkip to navigationSkip to main content

Generation of gene-of-interest double allele knockout clones in primary human T cells by CRISPR

*Corresponding author for this work
  • National University of Singapore
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Gene-of-interest (GOI) knockout is an important technique to study the genetic mechanisms of T cells. Here, we present a protocol to generate GOI double allele gene knockouts in primary human T cells by CRISPR, thus depleting proteins of interest expressed intracellularly or extracellularly in primary T cells. We describe steps for gRNA selection and efficiency validation, homology-directed repair (HDR) DNA template design and cloning, and genome editing and HDR gene insertion. We then detail clone isolation and GOI knockout validation. For complete details on the use and execution of this protocol, please refer to Wu et al.1

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

102445

Journal (Volume, Issue Number)

STAR Protocols (Volume 4, Issue 3)

Publication milestones

  • Published - 09/15/2023

Publication status

Published - 09/15/2023

Publication IDs

  • Scopus: 85164261216
  • PubMed: 37432856

Publication metrics

Metrics

Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

Funding Details

We thank the flow cytometry core facility team of The Life Sciences Institute (LSI), NUS, for sorting. This work was funded by NUS ILO TAP grant: TAP2002019-04-25 , Singapore Ministry of Health’s National Medical Research Council : MOH-000523 , and Ministry of Education , NUHSRO/2020/110/T1/SEED-MAR/06 . L.W. and J.C.T. were supported by research scholarships from Yong Loo Lin School of Medicine. We thank the flow cytometry core facility team of The Life Sciences Institute (LSI), NUS, for sorting. This work was funded by NUS ILO TAP grant: TAP2002019-04-25, Singapore Ministry of Health's National Medical Research Council: MOH-000523, and Ministry of Education, NUHSRO/2020/110/T1/SEED-MAR/06. L.W. and J.C.T. were supported by research scholarships from Yong Loo Lin School of Medicine. L.W. designed and conducted experiments and analyzed the data. J.C.T. performed the gRNA selection experiments. N.R.J.G. provided discussion and co-designed experiments. L.W. and N.R.J.G. wrote the paper, with input and final approval from all authors. National University of Singapore has filed a patent including some aspects of this work. Patent title: Engineered Immune Cells (PCT/SG2020/050090). Published September 10, 2020: WO 2020/180243 (L.W. N.R.J.G. and Joanna Brzostek).
FundersFunding numbers
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore
PCT/SG2020/050090, WO 2020/180243
LSI
-
NUS
MOH-000523, TAP2002019-04-25
MOE
NUHSRO/2020/110/T1/SEED-MAR/06